Big Pharma's Secret Weapon: Medicare Starts to Pay Off-Quietly
This article was originally published in RPM Report
Executive Summary
Pharma companies say Part D is a simple trade: increased volume in exchange for decreased prices. Six months into the program, the deal is working out very well for manufacturers-but don't expect anyone to celebrate just yet.